Literature DB >> 7745025

Identification of the main gonadal autoantigens in patients with adrenal insufficiency and associated ovarian failure.

O Winqvist1, G Gebre-Medhin, J Gustafsson, E M Ritzén, O Lundkvist, F A Karlsson, O Kämpe.   

Abstract

Autoimmune adrenal insufficiency is associated with premature ovarian failure at frequencies of 10-20%. In these patients a reactivity against an unknown steroid cell antigen in both the adrenal glands and gonads has been described. We have recently identified the cytochrome P450 enzyme 21-hydroxylase and the side-chain cleavage enzyme (SCC) as the major adrenal autoantigens in Addison's disease and the rare autoimmune polyendocrine syndrome type I (APS-I), respectively. In an attempt to identify the steroid cell antigen, sera from patients with Addison's disease (n = 13) and APS-I (n = 7) that reacted with Leydig cells were selected. Preparations of isolated human granulosa cells, isolated rat Leydig cells, and fractions of human placenta were used in Western blots. All sera were also tested against bacterially expressed 21-hydroxylase, SCC, and 17 alpha-hydroxylase. The SCC was recognized by sera from patients with Addison's disease and those with APS-I. In addition, a majority of the sera (n = 12) reacted with a novel 51-kilodalton autoantigen present in granulosa cells and placenta. The results show that the steroid cell autoantigen consists mainly of the SCC and a novel protein of unknown function.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7745025     DOI: 10.1210/jcem.80.5.7745025

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  12 in total

Review 1.  Xenobiotic-metabolizing enzymes as autoantigens in human autoimmune disorders. An update.

Authors:  E Boitier; P Beaune
Journal:  Clin Rev Allergy Immunol       Date:  2000-04       Impact factor: 8.667

Review 2.  Autoimmune polyglandular syndrome type 1.

Authors:  P Obermayer-Straub; C P Strassburg; M P Manns
Journal:  Clin Rev Allergy Immunol       Date:  2000-04       Impact factor: 8.667

Review 3.  Mechanisms and models of immune tolerance breakdown in the ovary.

Authors:  Mickie H Cheng; Lawrence M Nelson
Journal:  Semin Reprod Med       Date:  2011-10-03       Impact factor: 1.303

Review 4.  Multiplicity of molecular and cellular targets in human ovarian autoimmunity: an update.

Authors:  Eusebio S Pires
Journal:  J Assist Reprod Genet       Date:  2010-06-03       Impact factor: 3.412

5.  Autoimmune Regulator is required in female mice for optimal embryonic development and implantation†.

Authors:  Bryce D Warren; Soo H Ahn; Lynda K McGinnis; Geoffrey Grzesiak; Ren-Wei Su; Asgerally T Fazleabas; Lane K Christenson; Brian K Petroff; Margaret G Petroff
Journal:  Biol Reprod       Date:  2019-06-01       Impact factor: 4.285

6.  Screening for associated autoimmune disorders in Polish patients with Addison's disease.

Authors:  Marta Fichna; Piotr Fichna; Maria Gryczyńska; Jarosław Walkowiak; Magdalena Zurawek; Jerzy Sowiński
Journal:  Endocrine       Date:  2010-03-16       Impact factor: 3.633

7.  Aromatic-L-amino-acid decarboxylase, a pyridoxal phosphate-dependent enzyme, is a beta-cell autoantigen.

Authors:  F Rorsman; E S Husebye; O Winqvist; E Björk; F A Karlsson; O Kämpe
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-12       Impact factor: 11.205

8.  Clinical and serologic parallels to APS-I in patients with thymomas and autoantigen transcripts in their tumors.

Authors:  Anette S B Wolff; Jaanika Kärner; Jone F Owe; Bergithe E V Oftedal; Nils Erik Gilhus; Martina M Erichsen; Olle Kämpe; Anthony Meager; Pärt Peterson; Kai Kisand; Nick Willcox; Eystein S Husebye
Journal:  J Immunol       Date:  2014-09-17       Impact factor: 5.422

Review 9.  The immunofluorescence techniques in the diagnosis of endocrine autoimmune diseases.

Authors:  Corrado Betterle; Renato Zanchetta
Journal:  Auto Immun Highlights       Date:  2012-06-06

10.  Primary Ovarian Insufficiency in Women With Addison's Disease.

Authors:  Elinor C Vogt; Lars Breivik; Ellen C Røyrvik; Marianne Grytaas; Eystein S Husebye; Marianne Øksnes
Journal:  J Clin Endocrinol Metab       Date:  2021-06-16       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.